Magnolia officinalis, recorded in the "Shennong's Classic of Materia Medica" of China, has 1000 years history of medicinal use. Its core actives — Magnolol and Honokiol — achieve broad-spectrum antibacterial action through dual mechanisms of Physical Membrane Disruption and Biochemical Interference. It also suppresses the NF-κB inflammatory pathway at its source, significantly reducing TNF-α at ultra-low doses, with antioxidant capacity approaching Vitamin C.